Investigational Drug Lowers Tourette Relapse Risk in Kids
27/05/2026
Estudio sobre Ecopipam Children and adolescents with Tourette syndrome had a lower risk of relapses with investigational ecopipam, a phase
El instituto de investigación científica que podría recibir $4.2 mil millones en fondos públicos si los votantes de California aprueban…
Read more →Estudio sobre Ecopipam Children and adolescents with Tourette syndrome had a lower risk of relapses with investigational ecopipam, a phase
Suppressing a sneeze may have led to a spontaneous leak of cerebrospinal fluid (CSF) and air entering the skull of
NfL and Cognition Neurofilament light chain (NfL), a measure of neuronal injury, emerged as a key blood-based biomarker associated with
Introducción The interleukin-6 (IL-6) inhibitor satralizumab (Enspryng) met its primary endpoint in the phase III METEOROID trial of myelin oligodendrocyte